Bactec Kit Outer Labeling Only Required To Comply With “Drug Facts” Format
This article was originally published in The Tan Sheet
The individual OTC components in Becton Dickinson's Bactec Blood Culture Procedural Tray will not be required to carry "Drug Facts" labeling as long as the kit's outer package uses the OTC labeling format to describe the components, FDA says in a June 5 letter to the firm
You may also be interested in...
FDA's OTC labeling rules should not apply to blood culture "convenience" kits containing OTC drug components used by health care professionals, Becton, Dickinson & Co. asserts.
Zee Medical is seeking FDA exemption from OTC labeling rule requirements that each inactive ingredient be listed on a product. In a Sept. 15 application, the company requests it be "allowed to use the phrase 'may contain' to list inactive ingredients that may or may not be present" in its PainAid Pain Relief tablets.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC